Investing into psychedelics

CECORS, INC. (OTC PINK: CEOS) (“CeCors” or the “Company”), is pleased to announce that the Company is transitioning into the Psychedelics Market, with a direction that includes a complete overhaul of the management team, bringing the Company to current status and delivering exciting growth for our shareholders.

**The newly appointed management of PsyKey Inc. will oversee operations of CeCors as we look ahead to build a viable, sustainable, and innovative company that will become a category leader as psychedelics become legal in more and more jurisdictions.** The previous officers and/or directors no longer have any relationship with CeCors, and we wish them well in their future endeavors. The Company has begun the process of becoming current in its reporting obligations with the OTC Markets, beginning with financials, completing a successful audit, and updating new director biographies accordingly.

The Acquisition Agreement between the two companies allows CeCors to purchase all outstanding shares of PsyKey Inc., a Canadian federal corporation. PsyKey Inc. will operate as a wholly-owned Canadian subsidiary of CeCors until the Company achieves current status with OTC Markets. At that point, they will look to a name change to PsyKey World. The Company has completed an Authorized Share increase of 250 million shares, for a total of 500 million Authorized Shares in order to accommodate for the acquisition. There are no outstanding convertible notes, and all shares issued in consideration for the purchase of PsyKey Inc. will be subject to standard regulatory restriction periods.
https://www.reddit.com/r/StockMarket/comments/mkmwxk/investing_into_psychedelics/